Cargando…

An EAACI “European Survey on Adverse Systemic Reactions in Allergen Immunotherapy (EASSI)”: the methodology

At present, there is no European report on clinically relevant systemic reactions due to the regular use of allergen immunotherapy (AIT), administered either subcutaneously or sublingually (SCIT and SLIT, respectively) outside clinical trials. Using an electronic survey and a “harmonised terminology...

Descripción completa

Detalles Bibliográficos
Autores principales:	Calderón, Moises A, Rodríguez del Río, Pablo, Vidal, Carmen, Just, Jocelyne, Pfaar, Oliver, Linneberg, Allan, Demoly, Pascal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4113667/ https://www.ncbi.nlm.nih.gov/pubmed/25075276 http://dx.doi.org/10.1186/2045-7022-4-22

Ejemplares similares

EAACI: A European Declaration on Immunotherapy. Designing the future of allergen specific immunotherapy
por: Calderon, Moises A, et al.
Publicado: (2012)

EAACI Allergen Immunotherapy User's Guide
por: Alvaro‐Lozano, Montserrat, et al.
Publicado: (2020)

COVID‐19 pandemic and allergen immunotherapy—an EAACI survey
por: Pfaar, Oliver, et al.
Publicado: (2021)

Criteria used by health professionals on the selection of allergen immunotherapy in real clinical practice: Methodology
por: Caimmi, Davide, et al.
Publicado: (2023)

ARIA‐EAACI care pathways for allergen immunotherapy in respiratory allergy
por: Bousquet, Jean, et al.
Publicado: (2021)

Allergen immunotherapy and allergic rhinitis: false beliefs
por: Calderón, Moisés A, et al.
Publicado: (2013)

The effect of a new communication template on anticipated willingness to initiate or resume allergen immunotherapy: an internet-based patient survey
por: Calderon, Moises A., et al.
Publicado: (2015)

A meta-analysis of sublingual allergen immunotherapy and pharmacotherapy in pollen-induced seasonal allergic rhinoconjunctivitis
por: Devillier, Philippe, et al.
Publicado: (2014)

The Allergen Immunotherapy Adverse Events Registry: Setup & methodology of a European Academy of Allergy and Clinical Immunology taskforce project
por: Asllani, Julijana, et al.
Publicado: (2023)

CHOICE international survey: Clusters of allergen immunotherapy prescription from French and Spanish cohorts
por: Rodriguez del Rio, Pablo, et al.
Publicado: (2023)

Allergen exposure chambers: implementation in clinical trials in allergen immunotherapy
por: Pfaar, O., et al.
Publicado: (2020)

Allergen immunotherapy for respiratory allergy: Quality appraisal of observational comparative effectiveness studies using the REal Life Evidence AssessmeNt Tool. An EAACI methodology committee analysis
por: Di Bona, Danilo, et al.
Publicado: (2021)

Adverse events in children and adolescents undergoing allergen immunotherapy for respiratory allergies—Report from the Allergen Immunotherapy Adverse Events Registry (ADER), a European Academy of Allergy and Clinical Immunology taskforce
por: Asllani, Julijana, et al.
Publicado: (2023)

Digital health for allergen immunotherapy
por: Dramburg, Stephanie, et al.
Publicado: (2022)

Characteristics and management of sublingual allergen immunotherapy in children with allergic rhinitis and asthma induced by house dust mite allergens
por: Trebuchon, Florence, et al.
Publicado: (2014)

Placebo effects in allergen immunotherapy: an experts’ opinion
por: Frew, Anthony J., et al.
Publicado: (2018)

Allergen immunotherapy for allergic asthma: protocol for a systematic review
por: Dhami, Sangeeta, et al.
Publicado: (2016)

Erratum to: Allergen immunotherapy for allergic asthma: protocol for a systematic review
por: Dhami, Sangeeta, et al.
Publicado: (2017)

Pretreatment by omalizumab allows allergen-specific immunotherapy in children and young adult with severe allergic asthma
por: Lambert, Nathalie, et al.
Publicado: (2015)

Allergen immunotherapy for allergic rhinoconjunctivitis: protocol for a systematic review
por: Dhami, Sangeeta, et al.
Publicado: (2016)

Choosing the optimal dose in sublingual immunotherapy: Rationale for the 300 index of reactivity dose
por: Demoly, Pascal, et al.
Publicado: (2015)

Development of the EAACI% season definition a backup for a global application
por: Bastl, Maximilian, et al.
Publicado: (2022)

Management of the polyallergic patient with allergy immunotherapy: a practice-based approach
por: Demoly, Pascal, et al.
Publicado: (2016)

Clinical endpoints in allergen immunotherapy: State of the art 2022
por: Gerth van Wijk, Roy, et al.
Publicado: (2023)

Erratum to: Allergen immunotherapy for allergic rhinoconjunctivitis: protocol for a systematic review
por: Dhami, Sangeeta, et al.
Publicado: (2017)

The placebo effect in allergen-specific immunotherapy trials
por: Narkus, Annemie, et al.
Publicado: (2013)

Vaccination against infectious agents and allergen-specific immunotherapy: A critical analysis
por: Worm, Margitta, et al.
Publicado: (2023)

Adherence in allergen immunotherapy: Current situation and future implications
por: Gehrt, Francesca, et al.
Publicado: (2022)

Research needs in allergy: an EAACI position paper, in collaboration with EFA
por: Papadopoulos, Nikolaos G, et al.
Publicado: (2012)

Patient engagement and patient support programs in allergy immunotherapy: a call to action for improving long-term adherence
por: Demoly, Pascal, et al.
Publicado: (2016)

EAACI position paper on occupational rhinitis
por: Moscato, Gianna, et al.
Publicado: (2009)

“The value of pre- and co-seasonal sublingual immunotherapy in pollen-induced allergic rhinoconjunctivitis”
por: Demoly, Pascal, et al.
Publicado: (2015)

“A year-long, fortnightly, observational survey in three European countries of patients with respiratory allergies induced by house dust mites: Methodology, demographics and clinical characteristics”
por: Demoly, Pascal, et al.
Publicado: (2016)

Real-life evidence in allergen immunotherapy: Moving forward with mHealth apps
por: Sousa-Pinto, Bernardo, et al.
Publicado: (2023)

Clinical trials in allergen immunotherapy: current concepts and future needs
por: Pfaar, O., et al.
Publicado: (2018)

Mite-Allergic Rhinitis: How to Evaluate Clinical Efficacy in Allergen-Specific Immunotherapy Trials?
por: Pfaar, Oliver, et al.
Publicado: (2015)

A common language to assess allergic rhinitis control: results from a survey conducted during EAACI 2013 Congress
por: Hellings, Peter W., et al.
Publicado: (2015)

Diagnostic tools in Rhinology EAACI position paper
por: Scadding, Glenis, et al.
Publicado: (2011)

EAACI anaphylaxis guidelines: systematic review protocol
por: de Silva, Debra, et al.
Publicado: (2020)

Contraindications to immunotherapy: a global approach
por: Pitsios, C., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_jn070t9on2bspl275431n7asfv